ASHLEY RUTLEDGE: Open Payments
NPI 1124679246 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 26 payments from 10 companies in 2025. Trend: 2023 $797 · 2024 $933 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $340 |
| Abbott Laboratories | 4 | $186 |
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| Novo Nordisk Inc | 1 | $125 |
| Dexcom, Inc. | 1 | $108 |
| Amgen Inc. | 2 | $100 |
| ABBVIE INC. | 3 | $70 |
| Exact Sciences Corporation | 3 | $63 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
Products named: FREESTYLE LIBRE 3, KISUNLA, BREZTRI, ZEPBOUND, Wegovy, DEXCOM G7 GSS (161), REPATHA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
